U

    Universe Pharmaceuticals Inc (UPC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.58
    -0.32 (-6.53%)

    Market Cap: $3.04M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 25
    Reported Jul 3
    		$-9.44$0.00N/AMiss-11900.0%
    Mar 25
    Reported Apr 29
    		$0.00$0.00N/ABeat-100.0%
    Jun 24
    Reported Sep 20
    		$0.00$0.00N/ABeat-100.0%
    Dec 22
    Reported Feb 10
    		$-0.48$0.00N/AMiss-233.3%
    Jun 22
    Reported Aug 16
    		$0.08$0.00N/ABeat-63.8%
    Dec 21
    Reported Jan 31
    		$0.60$0.00N/ABeat+66.7%
    Jun 21
    Reported Aug 2
    		$0.44$0.00N/ABeat+467.0%
    Dec 20
    Reported Mar 24
    		$0.36$0.00N/ABeat+127.0%
    Sep 20
    Reported Dec 31
    		$0.22$0.00N/ABeat+39.3%
    Jun 20
    Reported Aug 17
    		$0.36$0.00N/ABeat+231.5%
    Mar 20
    Reported Jun 30
    		$0.08$0.00N/ABeat-28.5%
    Dec 19
    Reported Mar 31
    		$0.16$0.00N/ABeat+24.5%
    Sep 19
    Reported Dec 31
    		$0.16$0.00N/ABeat+24.5%
    Jun 19
    Reported Sep 30
    		$0.11$0.00N/ABeat-
    Mar 19
    Reported Jun 30
    		$0.11$0.00N/ABeat-
    Dec 18
    Reported Mar 31
    		$0.13$0.00N/ABeat-
    Sep 18
    Reported Dec 31
    		$0.13$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.50EV/EBITDA0.31x
    Price/FCF-0.21xFCF Yield-481.60%
    Profitability
    Profit Margin-11.00%Operating Margin-16.60%
    ROE-3.51%ROIC-7.52%
    Financial Health
    Debt/Equity0.13xInterest Coverage-11.89x
    Current Ratio4.05xQuick Ratio3.75x
    Trading Statistics
    Beta1.53Avg Volume1.40M
    52-Week High$17.9652-Week Low$2.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.14
    SMA 20$5.64
    SMA 50$5.04
    SMA 200$3.79
    EMA 10$5.12
    EMA 20$5.20
    EMA 50$4.87
    EMA 200$4.12

    MACD

    Line: 0.00Signal: 0.15Hist: -0.15

    ADX

    ADX: 36.6+DI: 26.6-DI: 14.1

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down8.0
    PSAR$8.21

    Bollinger Bands

    Upper Band$6.95
    Lower Band$4.33
    %B Position4635%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    44.4

    Momentum Oscillators

    Stoch %K9.5
    Stoch %D10.6
    Williams %R-100.0
    ROC (10d)-20.8%
    Momentum-1.20
    CCI (20d)-134.1
    MFI (14d)39.6

    Volatility Measures

    ATR (14d)$0.79(17.2%)
    StdDev (20d)0.65
    Hist Vol146.6%(High)

    Volume Flow

    VWAP$4.72
    OBV115.7M
    AD Line18.0B
    CMF (20d)0.337

    Volume Metrics

    Avg Vol (20d)97.6K
    Vol Ratio0.1x(Low)
    VWMA (20d)$6.47

    Pivot Points

    R3$6.41
    R2$5.98
    R1$5.44
    Pivot Point$5.01
    S1$4.47
    S2$4.04
    S3$3.50

    Advanced Oscillators

    TSI0.32
    Ultimate Osc40.2
    KST123.05

    Financial Data

    QuarterJun 2026Dec 2025Mar 2025Jun 2024Dec 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
    Total Revenue$9.04M$8.71M$9.15M$12.88M$13.84M$18.47MN/A$15.94MN/A$24.20M$24.20M$23.69M
    Cost of Revenue$5.81M$5.57M$5.99M$9.64M$9.78M$12.45MN/A$7.89MN/A$10.57M$10.57M$10.42M
    Gross Profit$3.23M$3.14M$3.16M$3.24M$4.06M$6.01MN/A$8.05MN/A$13.63M$13.63M$13.26M
    Operating Expenses$4.73M$3.73M$5.49M$4.98M$7.74M$5.87MN/A$17.98MN/A$10.93M$10.93M$9.45M
    R&D$86,443$574,925$96,836$86,503$2.61M$2.29M$0$7.49M$0$134,460$134,460$5.03M
    SG&A$0$0$3.19M$0$0$0$0$1.67M$0$0$0$2.37M
    Operating Income$-1,500,132$-589,158$-2,326,761$-1,740,137$-3,676,020$149,250N/A$-10,140,080N/A$2.70M$2.70M$4.01M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$126,156$103,296$128,745$136,613$82,219$74,569$0$74,011$0$88,389$88,389$54,933
    Income Before Tax$-1,554,813$-387,300$-3,284,755$-12,436,309$-4,139,577$258,931$0$-11,332,689$0$3.31M$3.31M$4.12M
    Income Tax Expense$0$0$-58,444$665,148$1.34M$974,358$487,179$-825,800$-412,900$1.58M$1.58M$-52,221
    Net Income$-1,554,813$-387,300$-3,284,755$-13,101,457$-5,447,634$-715,427N/A$-10,468,301N/A$1.73M$1.73M$4.17M
    EBITDA$-1,268,915$-36,211$-2,886,372$-12,050,839$-3,806,355$591,277N/A$-11,016,839N/A$3.69M$3.69M$4.38M
    EBIT$-1,500,132$-284,003$-3,156,011$-12,299,699$-4,057,360$333,497$74,623$-11,258,677$-5,070,039$3.40M$3.40M$4.17M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about UPC

    News

    Universe Pharmaceuticals Sets September 30, 2026 AGM With Contingent Reverse Stock Split Proposal

    Universe Pharmaceuticals (UPC) has scheduled its 2026 Annual General Meeting of Shareholders for September 30, 2026, in Ji’an, Jiangxi, China. The agenda includes the re-election of five directors and a contingent 1-for-10 share consolidation aimed at addressing potential Nasdaq minimum-price compliance issues. Spark, TipRanks' AI Analyst, rates UPC as Neutral due to deteriorated financial performance despite a relatively conservative balance sheet.

    TipRanks•9/1/26•
    Somewhat-Bearish

    Universe Pharmaceuticals Inc (NASDAQ: UPC) Share Price, UPC Stock News, UPC Share Price & Updates

    This article provides an overview of Universe Pharmaceuticals Inc. (NASDAQ: UPC) stock, including its current share price, key financial metrics such as market cap, volume, P/E ratio, and revenue. It also lists recent news regarding the company, such as a share consolidation and Nasdaq delisting notices, and presents detailed income statements, balance sheets, and cash flow statements, along with a peer comparison in the healthcare industry. The company profile highlights its focus on traditional Chinese medicine derivative products and distribution of third-party products in China.

    kalkine.ca•8/15/26•
    Somewhat-Bearish

    Universe Pharmaceuticals Inc (NASDAQ: UPC) Share Price, UPC Stock News, UPC Share Price & Updates

    This article provides an overview of Universe Pharmaceuticals Inc. (NASDAQ: UPC), including its current stock price, financial data, and recent news. It details the company's income statement, balance sheet, and cash flow for several past fiscal years, along with a peer comparison in the healthcare sector. The company profile highlights its business in manufacturing and distributing traditional Chinese medicine derivative products in China.

    Kalkine•8/14/26•
    Bearish

    Universe Pharmaceuticals Inc (UPC) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for Universe Pharmaceuticals Inc (UPC), detailing future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a peer comparison with other pharmaceutical companies like Biogen Inc and Amgen Inc. The financial forecasting covers EPS, Revenue, Net Profit, and EBIT, with data updated as of August 10, 2026.

    TradingKey•8/10/26•
    Bullish

    12 Health Care Stocks Moving In Monday's Intraday Session

    This article identifies twelve healthcare stocks experiencing significant movement during Monday's intraday trading session, highlighting both gainers and losers. Universe Pharmaceuticals (NASDAQ: UPC) saw the largest increase, while several other companies like SL Science Holding (NASDAQ: SLBT) and Autolus Therapeutics (NASDAQ: AUTL) also rose. Conversely, CalciMedica (NASDAQ: CALC), NewGenIvf Group (NASDAQ: NIVF), and Genprex (NASDAQ: GNPX) were among the decliners.

    Benzinga•8/3/26•
    Bullish

    Frequently Asked Questions About UPC

    Does UPC pay dividends?
    Universe Pharmaceuticals Inc (UPC) does not currently pay a regular dividend.
    What is UPC's market cap?
    Universe Pharmaceuticals Inc (UPC) has a market capitalization of $3.04M with a current stock price of $4.58.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In